Literature DB >> 15741927

Differentiating functional constipation from constipation-predominant irritable bowel syndrome: management implications.

Nicholas J Talley1.   

Abstract

Symptoms of constipation are commonly seen in medical practice. Once other medical causes have been excluded, distinguishing patients who have constipation-predominant irritable bowel syndrome (IBS) from those with functional constipation has been considered useful in terms of planning management. However, the criteria used to distinguish IBS from functional constipation are arguably arbitrary, and the availability of new therapeutic approaches may render such distinctions of little practical relevance. In this article, the author presents a review of the management implications of differentiating constipation-predominant IBS from functional constipation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741927

Source DB:  PubMed          Journal:  Rev Gastroenterol Disord        ISSN: 1533-001X


  6 in total

1.  Comparison of colonic transit time between patients with constipation-predominant irritable bowel syndrome and functional constipation.

Authors:  Reza Ansari; Sahand Sohrabi; Omid Ghanaie; Hiva Amjadi; Shahin Merat; Homayoun Vahedi; Morteza Khatibian
Journal:  Indian J Gastroenterol       Date:  2010-05-05

2.  Audit of constipation in a gastroenterology referral center.

Authors:  Guido Iantorno; Monica Cinquetti; Alessandro Mazzocchi; Antonio Morelli; Gabrio Bassotti
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

Review 3.  Symptom overlap and comorbidity of irritable bowel syndrome with other conditions.

Authors:  Christine L Frissora; Kenneth L Koch
Journal:  Curr Gastroenterol Rep       Date:  2005-08

4.  Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation.

Authors:  Anthony J Lembo; John F Johanson; Henry P Parkman; Satish S Rao; Philip B Miner; Ryuji Ueno
Journal:  Dig Dis Sci       Date:  2011-07-19       Impact factor: 3.199

5.  The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials.

Authors:  L Chang; A J Lembo; B J Lavins; S J Shiff; X Hao; J G Chickering; X D Jia; M G Currie; C B Kurtz; J M Johnston
Journal:  Aliment Pharmacol Ther       Date:  2014-10-13       Impact factor: 8.171

6.  Prevalence and Self-recognition of Chronic Constipation: Results of an Internet Survey.

Authors:  Akio Tamura; Toshihiko Tomita; Tadayuki Oshima; Fumihiko Toyoshima; Takahisa Yamasaki; Takuya Okugawa; Takashi Kondo; Tomoaki Kono; Katsuyuki Tozawa; Hisatomo Ikehara; Yoshio Ohda; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.